Multiple sclerosis. Biomarkers for deciding treatment
Meinl, E.; Voltz, R.
MMW Fortschritte der Medizin 146(Special Issue 2): 57-58
2004
ISSN/ISBN: 1438-3276 PMID: 15376703 Document Number: 584029
Document emailed within 1 workday
Related Documents
Satoh, J.-i. 2008: Molecular biomarkers for prediction of multiple sclerosis relapse Nihon Rinsho. Japanese Journal of Clinical Medicine 66(6): 1103-1111Sánchez-Chaparro, M.M.; Rodríguez-Sánchez, I.P.; Barrera-Saldaña, H.A.; Martínez-Villarreal, L.E.; Resendez-Pérez, D.; Gámez-Escobedo, I.A. 2015: MicroRNAs and their neuroimmunoregulator mechanisms in multiple sclerosis. Development of biomarkers for diagnosis Revista de Neurologia 60(12): 562-571
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Petit, H. 1973: Multiple sclerosis. Treatment Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 18(5): 548-549
Confavreux, C. 1994: Treatment of multiple sclerosis La Revue du Praticien 44(12): 1643-1648
Wührich, R. 1976: Treatment of multiple sclerosis Schweizerische Rundschau für Medizin Praxis 65(17): 495-498
Midgard, R. 2001: Treatment of multiple sclerosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(19): 2254
Frick, E.; Angstwurm, H.; Strauss, G. 1974: Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin Münchener Medizinische Wochenschrift 116(48): 2105-2112
Tanaka, M. 2014: Fingolimod treatment in multiple sclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 72(11): 2010-2014
Sivertseva, S.A.; Zhuravlev, M.N.; Shmurygina, E.A.; Dekhtiarenko, E.V.; Boĭko, A.N. 2009: Use of mitoxantrone in the treatment of multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(7 Suppl 2: 100-106
Martí-Vilalta, J.L.; Costa-Jussá, F.; Roig, C. 1981: Multiple sclerosis. Treatment interactions Medicina Clinica 77(6): 263
Schapiro, R.T. 1999: Medications used in the treatment of multiple sclerosis Physical Medicine and Rehabilitation Clinics of North America 10(2): 437-446 Ix
Silberberg, D.H. 1994: Specific treatment of multiple sclerosis Clinical Neuroscience 2(3-4): 271-274
Zephir, H.; De-Seze, J.; Senechal, O.; Stojkovic, T.; Ferriby, D.; Delisse, B.; Dubus, B.; Verier, A.; Hautecoeur, P.; Vermersch, P. 2002: Treatment of progressive multiple sclerosis with cyclophosphamide Revue Neurologique (Paris) 158(1): 65-69
Fryze, W.; Obiedziński, R. 1988: Our observations regarding the treatment of multiple sclerosis with TFX "Polfa" Neurologia i Neurochirurgia Polska 22(5): 475